Bank of New York Mellon Corp - THERAVANCE INC ownership

THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 151 filers reported holding THERAVANCE INC in Q4 2013. The put-call ratio across all filers is 0.69 and the average weighting 0.4%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of THERAVANCE INC
ValueSharesWeighting
Q4 2015$15,667,000
+63.6%
1,486,436
+11.5%
0.01%
+66.7%
Q3 2015$9,574,000
-62.3%
1,333,567
-5.1%
0.00%
-57.1%
Q2 2015$25,390,000
+20.4%
1,405,084
+4.8%
0.01%
+40.0%
Q1 2015$21,081,000
+23.4%
1,341,003
+11.1%
0.01%
+25.0%
Q4 2014$17,084,000
+138.1%
1,207,340
+187.6%
0.00%
+100.0%
Q3 2014$7,175,000
-72.0%
419,841
-51.2%
0.00%
-33.3%
Q2 2014$25,594,000
+173.5%
859,456
+184.1%
0.00%0.0%
Q1 2014$9,359,000
-18.3%
302,492
-5.8%
0.00%0.0%
Q4 2013$11,452,000
-62.3%
321,232
-56.8%
0.00%
-40.0%
Q3 2013$30,380,000
+133.5%
743,346
+120.2%
0.01%
+25.0%
Q2 2013$13,008,000337,5930.00%
Other shareholders
THERAVANCE INC shareholders Q4 2013
NameSharesValueWeighting ↓
Baupost Group 19,815,983$338,655,0005.90%
Litespeed Management, L.L.C. 2,670,695$45,642,0001.76%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 2,790,913$47,697,0001.76%
Proxima Capital Management, LLC 915,000$15,637,0001.69%
IRIDIAN ASSET MANAGEMENT LLC/CT 8,196,372$140,076,0001.44%
PERRY CAPITAL 1,831,099$31,293,0001.14%
Roundview Capital LLC 140,145$2,395,0001.08%
SECTORAL ASSET MANAGEMENT INC 971,438$16,602,0000.70%
Realm Partners LLC 139,982$2,392,0000.68%
BB BIOTECH AG 743,244$12,702,0000.52%
View complete list of THERAVANCE INC shareholders